CDC: Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative
The Centers for Disease Control and Prevention established the EGAPP initiative in 2004 to develop and test a systematic, evidence-based process for evaluating genetic tests and other applications of genomic technology that are moving rapidly from research to clinical practice. This information is needed urgently to help consumers, health care providers and payers, policy makers, and other stakeholders distinguish tests that are safe and useful. EGAPP established a stakeholders group in fall 2007 to provide important input on its products and processes. EGAPP also welcomes suggestions and comments from any individual or representative of a genetic testing stakeholder group.